Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Endo
Pharma
Novartis pays $245M to settle Exforge generic pay-for-delay suit
Novartis will pay $245 million in separate settlements to end an Exforge "pay-for-delay" antitrust lawsuit.
Angus Liu
Jan 3, 2023 11:22am
Already in bankruptcy, Endo halts Qwo production, lays off 90
Dec 7, 2022 10:50am
Endo plays it straight with new Peyronie's disease tool
Oct 28, 2022 9:05am
Endo continues patient-first ad approach for Dupuytren's
Oct 7, 2022 3:51pm
Endo's patent claims against Eagle don't hold up, again
Aug 19, 2022 11:20am
Endo files for bankruptcy, signs $450M opioid settlement
Aug 17, 2022 2:20pm